Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (93)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hoffmann, M.
Right arrow Articles by Raderer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, M.
Right arrow Articles by Raderer, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 10:1185-1189, 1999
© 1999 European Society for Medical Oncology

research-article

Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type

M. Hoffmann1, K. Kletter1, M. Diemling1, A. Becherer1, F. Pfeffel3, V. Petkov3, A. Chott4 and M. Raderer2,

1Departments of Nuclear Medicine University of Vienna Vienna, Austria
2Departments of Internal Medicine I University of Vienna Vienna, Austria
3Departments of Internal Medicine IV University of Vienna Vienna, Austria
4Departments of Clinical Pathology, University of Vienna Vienna, Austria

Correspondence to: M. Raderer, MD Department of Internal Medicine I, Division of Oncology University of Vienna Waehringer Guertel 18–20 A-1090 Vienna Austria E-mail: Markus.Raderer{at}akh-wien.ac.at

Background: On the basis of promising data on the use of fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) whole body positron emission tomography (WB-FDG-PET) in the staging of patients with lymphoma, we initiated a pilot series to evaluate the role of WB-FDG-PET in the staging of extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) type.

Patients and methods: We examined ten consecutive patients with histologically-verified MALT-type lymphomas of various origin before initiation of therapy. Nine patients had low-grade lymphomas (five cases of gastric lymphoma, two patients with lymphoma arising in the lung, one parotid and one lacrimal gland lymphoma, while one patient had a high-grade gastric lymphoma arising from a low-grade background. Two patients had stage El, seven had stage EII disease, and one presented with stage EIII. WB-FDG-PET scans were performed 40 min following the injection of 300–380 MBq of F18-FDG. The PET scans were correlated with extensive conventional staging including ophthalmologic investigation, otolaryngologic examination, gastroscopy, endosonography, enteroclysis, colonoscopy, CT of thorax and abdomen, and bone marrow biopsy.

Results: WB-FDG-PET documented no lymphoma in any of the 10 patients studied, as no focal tracer uptake was demonstrated in either gastric or extragastric lesions or in involved lymph nodes, irrespective of histologic grading. In three patients the scan showed a false negative result with respect to the MALT lesions but showed focal tracer uptake indicating tumor spread, which, however, was ruled out by further follow-up and biopsy, respectively, and was thus rated false positive. Due to these results, the study was discontinued prematurely after the first ten patients.

Conclusions: These discouraging results indicated that WB-FDG-PET is not useful for staging and follow-up of MALT-type lymphoma, and should therefore not be included in the clinical decision making process.

F-18 FDG-PET, MALT-lymphoma


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
J. Y. Y. Ngeow, R. H. H. Quek, D. C. E. Ng, S. W. Hee, M. Tao, L. C. Lim, Y. H. Tan, and S. T. Lim
High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma
Ann. Onc., September 1, 2009; 20(9): 1543 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
O. Maksimovic, W. A. Bethge, J. P. Pintoffl, M. Vogel, C. D. Claussen, R. Bares, and M. Horger
Marginal Zone B-Cell Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue Type: Imaging Findings
Am. J. Roentgenol., September 1, 2008; 191(3): 921 - 930.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
Y. A Bae, K. S. Lee, J. Han, Y.-H. Ko, B.-T. Kim, M. J. Chung, and T. S. Kim
Marginal Zone B-Cell Lymphoma of Bronchus-Associated Lymphoid Tissue*: Imaging Findings in 21 Patients
Chest, February 1, 2008; 133(2): 433 - 440.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
T. C. Kwee, R. M. Kwee, and R. A. J. Nievelstein
Imaging in staging of malignant lymphoma: a systematic review
Blood, January 15, 2008; 111(2): 504 - 516.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. Seam, M. E. Juweid, and B. D. Cheson
The role of FDG-PET scans in patients with lymphoma
Blood, November 15, 2007; 110(10): 3507 - 3516.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
D. J. A. Margolis, J. M. Hoffman, R. J. Herfkens, R. B. Jeffrey, A. Quon, and S. S. Gambhir
Molecular Imaging Techniques in Body Imaging
Radiology, November 1, 2007; 245(2): 333 - 356.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
S. Kako, K. Izutsu, Y. Ota, Y. Minatani, M. Sugaya, T. Momose, K. Ohtomo, Y. Kanda, S. Chiba, T. Motokura, et al.
FDG-PET in T-cell and NK-cell neoplasms
Ann. Onc., October 1, 2007; 18(10): 1685 - 1690.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
H. Tsai, S Li, A. Ng, B Silver, M. Stevenson, and P. Mauch
Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma
Ann. Onc., April 1, 2007; 18(4): 672 - 678.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. E. Juweid, S. Stroobants, O. S. Hoekstra, F. M. Mottaghy, M. Dietlein, A. Guermazi, G. A. Wiseman, L. Kostakoglu, K. Scheidhauer, A. Buck, et al.
Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma
J. Clin. Oncol., February 10, 2007; 25(5): 571 - 578.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. D. Cheson, B. Pfistner, M. E. Juweid, R. D. Gascoyne, L. Specht, S. J. Horning, B. Coiffier, R. I. Fisher, A. Hagenbeek, E. Zucca, et al.
Revised Response Criteria for Malignant Lymphoma
J. Clin. Oncol., February 10, 2007; 25(5): 579 - 586.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
M Hoffmann, S Wohrer, A Becherer, A Chott, B Streubel, K Kletter, and M Raderer
18F-Fluoro-deoxy-glucose positron emission tomography in lymphoma of mucosa-associated lymphoid tissue: histology makes the difference
Ann. Onc., December 1, 2006; 17(12): 1761 - 1765.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. Hadithi, M. Mallant, J. Oudejans, J.-H. T.M. van Waesberghe, C. J. Mulder, and E. F.I. Comans
18F-FDG PET Versus CT for the Detection of Enteropathy-Associated T-Cell Lymphoma in Refractory Celiac Disease
J. Nucl. Med., October 1, 2006; 47(10): 1622 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. P. Beal, H. W. Yeung, and J. Yahalom
FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases
Ann. Onc., March 1, 2005; 16(3): 473 - 480.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
T. Kazama, S. C. Faria, V. Varavithya, S. Phongkitkarun, H. Ito, and H. A. Macapinlac
FDG PET in the Evaluation of Treatment for Lymphoma: Clinical Usefulness and Pitfalls
RadioGraphics, January 1, 2005; 25(1): 191 - 207.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
R. Kumar, Y. Xiu, S. Potenta, A. Mavi, H. Zhuang, J. Q. Yu, T. Dhurairaj, S. Dadparvar, and A. Alavi
18F-FDG PET for Evaluation of the Treatment Response in Patients with Gastrointestinal Tract Lymphomas
J. Nucl. Med., November 1, 2004; 45(11): 1796 - 1803.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Rohren, T. G. Turkington, and R. E. Coleman
Clinical Applications of PET in Oncology
Radiology, May 1, 2004; 231(2): 305 - 332.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
J. W. Friedberg and V. Chengazi
PET Scans in the Staging of Lymphoma: Current Status
Oncologist, October 1, 2003; 8(5): 438 - 447.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Elstrom, L. Guan, G. Baker, K. Nakhoda, J.-A. Vergilio, H. Zhuang, S. Pitsilos, A. Bagg, L. Downs, A. Mehrotra, et al.
Utility of FDG-PET scanning in lymphoma by WHO classification
Blood, May 15, 2003; 101(10): 3875 - 3876.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M Hoffmann, H Vogelsang, K Kletter, G Zettinig, A Chott, and M Raderer
18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma
Gut, March 1, 2003; 52(3): 347 - 351.
[Abstract] [Full Text] [PDF]

Home page
 RadioGraphicsHome page
L. Kostakoglu, H. Agress Jr, and S. J. Goldsmith
Clinical Role of FDG PET in Evaluation of Cancer Patients
RadioGraphics, March 1, 2003; 23(2): 315 - 340.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. Kostakoglu and S. J. Goldsmith
18F-FDG PET Evaluation of the Response to Therapy for Lymphoma and for Breast, Lung, and Colorectal Carcinoma
J. Nucl. Med., February 1, 2003; 44(2): 224 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
G. Zettinig, A. Becherer, M. Szabo, M. Uffmann, R. Dudczak, P. Valent, and K. Kletter
FDG Positron Emission Tomography in Patients with Systemic Mastocytosis
Am. J. Roentgenol., November 1, 2002; 179(5): 1235 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Trojan, M. Jermann, C. Taverna, and T. F. Hany
Fusion PET-CT imaging of neurolymphomatosis
Ann. Onc., May 1, 2002; 13(5): 802 - 805.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps
A Tabulated Summary of the FDG PET Literature
J. Nucl. Med., May 1, 2001; 42(90050): 1S - 93.
[Full Text] [PDF]

Home page
 JNMHome page
P. J. Lugtenburg, B. Löwenberg, R. Valkema, H.-Y. Oei, S. W. Lamberts, M. J. Eijkemans, W. L. van Putten, and E. P. Krenning
Somatostatin Receptor Scintigraphy in the Initial Staging of Low-Grade Non-Hodgkin's Lymphomas
J. Nucl. Med., February 1, 2001; 42(2): 222 - 229.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.